Global Irritable Bowel Syndrome (IBS) Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use

  • Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

    The report forecast global Irritable Bowel Syndrome (IBS) market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024.

    The report offers detailed coverage of Irritable Bowel Syndrome (IBS) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Irritable Bowel Syndrome (IBS) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

    First, this report covers the present status and the future prospects of the global Irritable Bowel Syndrome (IBS) market for 2015-2024.

    And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

    At the same time, we classify Irritable Bowel Syndrome (IBS) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

    Finally, the report provides detailed profile and data information analysis of leading Irritable Bowel Syndrome (IBS) company.

    Key Content of Chapters as follows (Including and can be customized) :

    Part 1:

    Market Overview, Development, and Segment by Type, Application & Region

    Part 2:

    Company information, Sales, Cost, Margin etc.

    Part 3:

    Global Market by company, Type, Application & Geography

    Part 4:

    Asia-Pacific Market by Type, Application & Geography

    Part 5:

    Europe Market by Type, Application & Geography

    Part 6:

    North America Market by Type, Application & Geography

    Part 7:

    South America Market by Type, Application & Geography

    Part 8:

    Middle East & Africa Market by Type, Application & Geography

    Part 9:

    Market Features

    Part 10:

    Investment Opportunity

    Part 11:

    Conclusion

    Market Segment as follows:

    By Region

    Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

    Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

    North America[United States, Canada, Mexico]

    Middle East & Africa[GCC, North Africa, South Africa]

    South America[Brazil, Argentina, Columbia, Chile, Peru]

    Key Companies

    Valeant Pharmaceuticals

    Allergan

    Takeda

    Sucampo Pharmaceuticals

    McNeil Consumer Healthcare

    Sebela Pharmaceuticals

    Astellas Pharmaceuticals

    IM HealthScience

    Market by Type

    IBS-D Drug

    IBS-C Drug

    Others

    Market by Application

    Women

    Men

     

  • Table of Content

    Part 1 Market Overview

    1.1 Market Definition

    1.2 Market Development

    1.3 By Type

    1.4 By Application

    1.5 By Region

    Part 2 Key Companies

    2.1 Valeant Pharmaceuticals

    2.1.1 Company Profile

    2.1.2 Products & Services Overview

    2.1.3 Sales Data List

    2.2 Allergan

    2.3 Takeda

    2.4 Sucampo Pharmaceuticals

    2.5 McNeil Consumer Healthcare

    2.6 Sebela Pharmaceuticals

    2.7 Astellas Pharmaceuticals

    2.8 IM HealthScience

    Part 3 Global Market Status and Future Forecast

    3.1 Global Market by Region

    3.2 Global Market by Company

    3.3 Global Market by Type

    3.4 Global Market by Application

    3.5 Global Market by Forecast

    Part 4 Asia-Pacific Market Status and Future Forecast

    4.1 Asia-Pacific Market by Type

    4.2 Asia-Pacific Market by Application

    4.3 Asia-Pacific Market by Geography

    4.3.1 China Market Status and Future Forecast

    4.3.2 Southeast Asia Market Status and Future Forecast

    4.3.3 India Market Status and Future Forecast

    4.3.4 Japan Market Status and Future Forecast

    4.3.5 Korea Market Status and Future Forecast

    4.3.6 Oceania Market Status and Future Forecast

    4.4 Asia-Pacific Market by Forecast

    Part 5 Europe Market Status and Future Forecast

    5.1 Europe Market by Type

    5.2 Europe Market by Application

    5.3 Europe Market by Geography

    5.3.1 Germany Market Status and Future Forecast

    5.3.2 UK Market Status and Future Forecast

    5.3.3 France Market Status and Future Forecast

    5.3.4 Italy Market Status and Future Forecast

    5.3.5 Russia Market Status and Future Forecast

    5.3.6 Spain Market Status and Future Forecast

    5.3.6 Netherlands Market Status and Future Forecast

    5.3.7 Turkey Market Status and Future Forecast

    5.3.6 Switzerland Market Status and Future Forecast

    5.4 Europe Market by Forecast

    Part 6 North America Market Status and Future Forecast

    6.1 North America Market by Type

    6.2 North America Market by Application

    6.3 North America Market by Geography

    6.3.1 United States Market Status and Future Forecast

    6.3.2 Canada Market Status and Future Forecast

    6.3.3 Mexico Market Status and Future Forecast

    6.4 North America Market by Forecast

    Part 7 South America Market Status and Future Forecast

    7.1 South America Market by Type

    7.2 South America Market by Application

    7.3 South America Market by Geography

    7.3.1 Brazil Market Status and Future Forecast

    7.3.2 Argentina Market Status and Future Forecast

    7.3.3 Columbia Market Status and Future Forecast

    7.3.4 Chile Market Status and Future Forecast

    7.3.5 Peru Market Status and Future Forecast

    7.4 South America Market by Forecast

    Part 8 Middle East & Africa Market Status and Future Forecast

    8.1 Middle East & Africa Market by Type

    8.2 Middle East & Africa Market by Application

    8.3 Middle East & Africa Market by Geography

    8.3.1 GCC Market Status and Future Forecast

    8.3.2 North Africa Market Status and Future Forecast

    8.3.3 South Africa Market Status and Future Forecast

    8.4 Middle East & Africa Market by Forecast

    Part 9 Market Features

    9.1 Product Features

    9.2 Price Features

    9.3 Channel Features

    9.4 Purchasing Features

    Part 10 Investment Opportunity

    10.1 Regional Investment Opportunity

    10.2 Industry Investment Opportunity

    Part 11 Conclusion

     

This is a single user license, allowing one specific user access to the product.

This is an enterprise license, allowing all employees within your organisation access to the product.

Need Assistance ?

Our Clients